Laboratory diagnosis of HIV in adults: A review of current methods

Clinical Infectious Diseases

Volumn 57, Issue 5, 2013, Pages 712-718

  Cornett, Julia Kang ^a   Kirn, Thomas J ^a,b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

diagnosis; HIV; human immunodeficiency virus

Indexed keywords

ALGORITHM; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; HEALTH CARE COST; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; LABORATORY DIAGNOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; TURNAROUND TIME; UNITED STATES; WESTERN BLOTTING;

DIAGNOSIS; HIV; HUMAN IMMUNODEFICIENCY VIRUS;

ALGORITHMS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CLINICAL LABORATORY TECHNIQUES; HIV INFECTIONS; HUMANS; UNITED STATES;

EID: 84881470534     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit281     Document Type: Review

References (46)

1. Centers for Disease Control and Prevention. HIV surveillance - United States, 1981-2008. MMWR Morb Mortal Wkly Rep 2011; 60:689-93.
2. US Preventive Services Task Force. Screening for HIV: Recommendation statement. Issued July 2005, amended 2 April 2007. AHRQ publication No. 07-0597-EF-2. Available at: Http://www.uspreventiveser vicestaskforce.org/ uspstf05/hiv/hivrs.htm. Accessed 11 July 2012.
3. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR Recomm Rep 2006; 55(RR-14):1-17.
4. World Health Organization. Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report. Geneva, Switzerland: WHO, 2010. Available at: Http://www.who.int/hiv/pub/ 2010progressreport/summary. Accessed 18 May 2012.
5. Prejean J, Song R, Hernandez A, Ziebell R, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011; 6:e17502. doi:10.1371/journal. pone.0017502.
6. Clinical and Laboratory Standards Institute. Criteria for laboratory testing and diagnosis of human immunodeficiency virus infection: Approved guideline. Document No. M53-A.Wayne, PA: CLSI, 2011.
7. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195: 951-9.
8. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-9.
9. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9.
10. Daskalakis DC. Diagnostic testing: Evolving technology and testing strategies. Top Antivir Med 2011; 19:18-22.
11. Morrison CS, Demers K, Kwok C, et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS 2010; 24:573-82.
12. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-93.
13. Cohen MS, Shaw GM, McMichael AJ. Acute HIV-1 infection. N Engl J Med 2011; 364:1943-54.
14. Powers KA, Ghani AC, Miller WC, et al. Role of acute infection in HIV transmission - authors' reply. Lancet 2011; 378:1914-5.
15. Owen SM. Testing for acute HIV infection: Implications for treatment as prevention. Curr Opin HIVAIDS 2012; 7:125-30.
16. Murphy G, Aitken C. HIV testing - the perspective from across the pond. J Clin Virol 2011; 52(suppl 1):S71-6.
17. Masciotra S, McDougal JS, Feldman J, et al. Evaluation of an alternative HIV diagnostic algorithm using specimens fromseroconversion panels and persons with established HIV infections. J Clin Virol 2011; 52(suppl 1): S17-22.
18. Pandori MW, Hackett J Jr, Louie B, et al. Assessment of the ability of a fourth generation immunoassay for HIV antibody and p24 antigen to detect both acute and recent HIV infection in a high-risk setting. J Clin Microbiol 2009; 47:2639-42.
19. Chavez P, Wesolowski L, Patel P, et al. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol 2011; 52(suppl 1):S51-5.
20. Bentsen C, McLaughlin L, Mitchell E, et al. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma. J Clin Virol 2011; 52(suppl 1):S57-61.
21. Branson BM, Mermin J. Establishing the diagnosis of HIV infection: New tests and a new algorithm for the United States. J Clin Virol 2011; 52(suppl 1):S3-4.
22. Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008; 46:1588-95.
23. Patel P, MacKellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010; 170:66-74.
24. Schito ML, D'Souza MP, Owen SM, et al. Challenges for rapid molecular HIV diagnostics. J Infect Dis 2010; 201(suppl 1):S1-6.
25. Tanriverdi S, Chen L, Chen S. A rapid and automated sample-to-result HIV load test for near-patient application. J Infect Dis 2010; 201(suppl 1):S52-8.
26. Pau CP, Wells SK, Owen SM, et al. Development of a simple, rapid and inexpensive method for the qualitative detection of HIV-1 RNA. In: Proceedings of the 2010 HIV Diagnostics Conference, Orlando, FL, March 2010.
27. Mazzola LT, Arsham AM, Pederson AM, et al. Innovative point-of-care HIV viral load detection in RLS. Proceedings of the 2010 HIV Diagnostics Conference, Orlando, FL, March 2010.
28. Greenwald JL, Burstein GR, Pincus J, et al. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006; 8:125-31.
29. Stekler J, Wood RW, Swenson PD, et al. Negative rapid HIV antibody testing during early HIV infection. Ann Intern Med 2007; 147:147-8.
30. Delaney KP, Branson BM, Uniyal A, et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis 2011; 52:257-63.
31. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a high-incidence population: Is antibody testing alone good enough?. Clin Infect Dis 2009; 49:444-53.
32. Pai NP. Point-of-care diagnostics for HIV and tuberculosis: Landscape, pipeline, and unmet needs. Discov Med 2012; 13:35-45.
33. Food and Drug Administration. OraQuick® In-Home HIV Test. Blood Products Advisory Committee briefing document: Available for public release. Meeting date: 15 May 2012. Available at: Http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Blood VaccinesandOtherBiologics/ BloodProductsAdvisoryCommittee/UCM 303652.pdf. Accessed 14 April 2012.
34. Fox J, Dunn H, O'Shea S. Low rates of p24 antigen detection using a fourth generation point of care HIV test. Sex Transm Infect 2011; 87: 178-9.
35. Beelaert G, Fransen K. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J Virol Methods 2010; 168: 218-22.
36. Parpia ZA, Elghanian R, Nabatiyan A, et al. P24 antigen rapid test for diagnosis of acute pediatric HIV infection. J Acquir Immune Defic Syndr 2010; 55:413-9.
37. Workman S, Wells SK, Pau CP, et al. Rapid detection of HIV-1 p24 antigen using magnetic immuno-chromatography (MICT). J Virol Methods 2009; 160:14-21.
38. Centers for Disease Control and Prevention. Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989; 38(suppl 7):1-7.
39. Styer LM, Sullivan TJ, Parker MM. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. J Clin Virol 2011; 52(suppl 1):S35-40.
40. Dragavon J, Gallardo C, Espinosa E, et al. Use of Multispot HIV-1/HIV-2 rapid test to confirm HIV-1/HIV-2 Plus O Enzyme Immunoassay results, shorten reporting time for HIV testing and identify cryptic HIV-2 infection. In: HIV Diagnostics Conference, Atlanta, GA, 12-14 December 2010. Available at: Http://www.hivtestingconference.org/PDF/Presentations/Coombs.pdf. Accessed 11 July 2012.
41. Centers for Disease Control and Prevention. HIV-2 infection surveillance - United States, 1987-2009. MMWR Morb Mortal Wkly Rep 2011; 60:985-8.
42. Wesolowski LG, Delaney KP, Hart C. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors. J Clin Virol 2011; 52(suppl 1):S45-9.
43. Joint United Nations Programme on HIV/AIDS. AIDS at 30: Nations at the crossroads. Available at: Http://www.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2011/20110531-JC2095E-aids-at-30-section0.pdf. Accessed 14 April 2012.
44. Cleary PD, Van Devanter N, Rogers TF, et al. Behavior changes after notification of HIV infection. Am J Public Health 1991; 81: 1586-90.
45. Fox R, Odaka NJ, Brookmeyer R, et al. Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS 1987; 1: 241-6.
46. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 2010; 16:1062-9.